Literature DB >> 15960966

Stem cells for lung cancer?

Anton Berns1.   

Abstract

Stem cells are believed to be crucial players in tumor development. There is much interest in identifying those compartments that harbor stem cells involved in lung cancer, given the high incidence and recurrence rate of this disease. In this issue of Cell, Kim and colleagues describe a niche in the bronchioalveolar duct junction of adult mouse lung that harbors stem cells from which adenocarcinomas are likely to arise. They enriched, propagated, and differentiated these stem cells in vitro and found that they were activated by the oncogenic protein K-ras. This study provides exciting insights into how the stem cell compartment operates during both normal lung-tissue homeostasis and the development of lung cancer. The new work offers perspectives on possible therapeutic interventions to combat lung cancer.

Entities:  

Mesh:

Year:  2005        PMID: 15960966     DOI: 10.1016/j.cell.2005.06.004

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  23 in total

1.  TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma.

Authors:  Naoki Oshimori; Daniel Oristian; Elaine Fuchs
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

Review 2.  Stem cells in the lung.

Authors:  Xiaoming Liu; Ryan R Driskell; John F Engelhardt
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

3.  Expression of the jaagsiekte sheep retrovirus envelope glycoprotein is sufficient to induce lung tumors in sheep.

Authors:  Marco Caporale; Christina Cousens; Patrizia Centorame; Chiara Pinoni; Marcelo De las Heras; Massimo Palmarini
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer.

Authors:  Haiyang Chen; Kazuhiko Shien; Ken Suzawa; Kazunori Tsukuda; Shuta Tomida; Hiroki Sato; Hidejiro Torigoe; Mototsugu Watanabe; Kei Namba; Hiromasa Yamamoto; Junichi Soh; Hiroaki Asano; Shinichiro Miyoshi; Shinichi Toyooka
Journal:  Oncol Lett       Date:  2017-07-26       Impact factor: 2.967

5.  Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell-like properties in cancer cells.

Authors:  Kazuhiko Shien; Shinichi Toyooka; Hiromasa Yamamoto; Junichi Soh; Masaru Jida; Kelsie L Thu; Shinsuke Hashida; Yuho Maki; Eiki Ichihara; Hiroaki Asano; Kazunori Tsukuda; Nagio Takigawa; Katsuyuki Kiura; Adi F Gazdar; Wan L Lam; Shinichiro Miyoshi
Journal:  Cancer Res       Date:  2013-03-29       Impact factor: 12.701

Review 6.  Cellular and molecular biology of small cell lung cancer: an overview.

Authors:  Niki Karachaliou; Sara Pilotto; Chiara Lazzari; Emilio Bria; Filippo de Marinis; Rafael Rosell
Journal:  Transl Lung Cancer Res       Date:  2016-02

Review 7.  Lung cancer stem cells: progress and prospects.

Authors:  Amber Lundin; Barbara Driscoll
Journal:  Cancer Lett       Date:  2012-08-17       Impact factor: 8.679

Review 8.  Recent progress on tissue-resident adult stem cell biology and their therapeutic implications.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Stem Cell Rev       Date:  2008       Impact factor: 5.739

9.  Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.

Authors:  Feng Jiang; Qi Qiu; Abha Khanna; Nevins W Todd; Janaki Deepak; Lingxiao Xing; Huijun Wang; Zhenqiu Liu; Yun Su; Sanford A Stass; Ruth L Katz
Journal:  Mol Cancer Res       Date:  2009-03-10       Impact factor: 5.852

Review 10.  Stemming cancer: functional genomics of cancer stem cells in solid tumors.

Authors:  C R A Regenbrecht; H Lehrach; J Adjaye
Journal:  Stem Cell Rev       Date:  2008-12       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.